:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ying Wei, Yong Tian, Ruixiang Cui, Ying Wang, Jia Liu, Guang Wang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Diabetes, Obesity and Metabolism
Online-Zugang:	https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70513
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes
von: Xiaopu Wang, et al.
Veröffentlicht: (2024)

Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA 1c
von: Guangxin Han, et al.
Veröffentlicht: (2025)

CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
von: Roland H. Stimson, et al.
Veröffentlicht: (2025)

Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
von: Wolfgang Landgraf, et al.
Veröffentlicht: (2025)

Correction to “The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes”
Veröffentlicht: (2025)

Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
von: Jiaqiang Zhang, et al.
Veröffentlicht: (2025)

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM
von: Ran Guo, et al.
Veröffentlicht: (2025)

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
von: Ying Zhu, et al.
Veröffentlicht: (2025)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
von: Moses Yidong Lim, et al.
Veröffentlicht: (2026)

Five‐year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England
von: Atanu Bhattacharjee, et al.
Veröffentlicht: (2025)

Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline HbA1c , BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1–5
von: Alice Y. Y. Cheng, et al.
Veröffentlicht: (2025)

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
von: Wanling Lu, et al.
Veröffentlicht: (2025)

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
von: Yongwen Zhou, et al.
Veröffentlicht: (2025)

Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue
von: Richard Sotorník, et al.
Veröffentlicht: (2025)

Distribution of HbA1c Levels in Patients With GCK ‐ MODY : A Worldwide Literature‐Based Retrospective Analysis
von: Yihan Zhao, et al.
Veröffentlicht: (2026)

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
von: Stephanie L. Samuels, et al.
Veröffentlicht: (2024)

HbA1c ≤ 6.5% in Early Type 2 Diabetes: Threshold, Trajectory, or Marker of Integrated Risk Management?
von: Man Sun, et al.
Veröffentlicht: (2026)

Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
von: Julie Mount, et al.
Veröffentlicht: (2026)

Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial
von: Hertzel C. Gerstein, et al.
Veröffentlicht: (2024)

Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
von: Ajenthen G. Ranjan, et al.
Veröffentlicht: (2025)

Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
von: Nan Dai, et al.
Veröffentlicht: (2024)

Ethnic variation in the relationship between ectopic fat and insulin resistance: Potential contributions of deep subcutaneous adipose tissue, rs1443512 in HOTAIR , and rs6712203 in COBLL1
von: Francis de Zegher, et al.
Veröffentlicht: (2024)

Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials
von: Masashi Hasebe, et al.
Veröffentlicht: (2025)

Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
von: Juan P. Frías, et al.
Veröffentlicht: (2025)

Glycaemic impact of the pre‐exercise timing of an elevated glucose target implemented using an automated insulin delivery system in adults with type 1 diabetes
von: Dale J. Morrison, et al.
Veröffentlicht: (2025)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
von: Pareeta Kotecha, et al.
Veröffentlicht: (2024)

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
von: Mohmmad Alghamdi, et al.
Veröffentlicht: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
von: Jia‐Jie Wang, et al.
Veröffentlicht: (2024)

Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems
von: Lauren V. Turner, et al.
Veröffentlicht: (2024)

Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
von: Samuel Seidu, et al.
Veröffentlicht: (2026)

Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
von: Xianglin Wu, et al.
Veröffentlicht: (2025)

Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
von: Stephanie A. Hooker, et al.
Veröffentlicht: (2026)

Risk of recurrent diabetic ketoacidosis following initiation of sodium‐glucose co‐transporter 2 inhibitors in patients with an insulin‐deficient diabetes and prior diabetic ketoacidosis: An observational cohort study
von: Anat Tsur, et al.
Veröffentlicht: (2026)

Effects of insulin‐induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes
von: Therese Wilbek Fabricius, et al.
Veröffentlicht: (2025)

Post‐exercise glycaemic control for 24 h: Fasted morning exercise with and without glucagon in adults with type 1 diabetes using automated insulin delivery
von: Clara Solà, et al.
Veröffentlicht: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
von: Irl B. Hirsch, et al.
Veröffentlicht: (2024)

Biological aging mediates the associations of metabolic score for insulin resistance with all‐cause and cardiovascular disease mortality among US adults: A nationwide cohort study
von: Xiaoxuan Li, et al.
Veröffentlicht: (2024)

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
von: Howard Wolpert, et al.
Veröffentlicht: (2025)

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
von: Yaxin Wang, et al.
Veröffentlicht: (2024)

Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
von: Rui Sun, et al.
Veröffentlicht: (2025)